Infection in LVAD patient with obesity
Left ventricle devices are considered as the available option for treatment of the last-stage heart failure. Despite improvement of implantable device, infections is still occurred and it can be life-threatening. In most cases long-term use of this tools is almost impossible. This is the case mostly because of mostly infection that is involved with the implant primarily the driveline exit site, this is a significant problem. Once the disease is identified it is considered as life-threatening and also hard to treat, highly reducing the chances of leaving with the device, from there henceforth the quality of the patient life might be compromised (Raymond et al, 2010) Statistically, it has been viewed that patients with left ventricle assisted devices have a higher risk of developing an infection at the driveline exit site after getting the in-plant especially if they continue to gain weight during the first sixty days of the in-plant (Martin et al, 2010).
Inclusion and Exclusion criteria Inclusion Criteria is left ventricle failure, details of a physical examination performed within two weeks of the VDA implantation, comprehensive laboratory test and Obesity effects on VDA transplant. Exclusion Criteria is age <19 years, pregnant women, people with other diseases that are not related to the heart and long-term solution to the ventricular assist devices infections. Terms of the search An electronic database search was conducted in PubMed, CINAHL, Embase, and Cochrane on 11/10/2017. Search term on Pubmed is ("LVAD" [Tiab] OR “LVAD” OR "BiVAD" OR “BiVAD[Tiab]" OR "ventric* assist device" OR "Left ventric* assist device" OR "Biventricular assist device" OR "Biventricle assist device" OR "heart assist device[Tiab]" OR “heart assist device" OR "Heart-Assist Devices/instrumentation"[Mesh] OR "Heart-Assist Devices/methods"[Mesh] OR "Heart-Assist Devices/standards"[Mesh] OR "Heart-Assist Devices/supply and distribution"[Mesh] OR "Heart-Assist Devices/therapeutic use"[Mesh] OR "Heart-Assist Devices/therapy"[Mesh] OR "Heart-Assist Devices/utilization"[Mesh]) AND (Overweight OR “Overweight” [Tiab] OR "Overweight"[Mesh] OR "Obesity" OR "Obesity[Tiab]" OR "Obesity"[Mesh] OR "Obesity, Morbid"[Mesh] OR “body mass index” OR “bmi” OR “body mass index” [Tiab] OR “BMI” [Tiab] OR "Body Mass Index"[Mesh]) AND (("Infection” OR “Infection”[Tiab] OR “Infection"[Mesh]) OR ("wound infection" OR “Wound infection”[Tiab] OR "Wound Infection"[Mesh]) OR ("surgical wound infection" OR “surgical wound infection”[Tiab] OR "Surgical Wound Infection"[Mesh] OR "surgical site infection" OR “Surgical site infection”[Tiab] OR "SSI" OR “SSI”[Tiab]) OR ("Blood stream infection" OR "Blood stream infection"[Tiab] OR "BSI" OR "Bacteremia" OR "Bacteremia"[Mesh])).
On CINAHL, search term with ((((MH "Heart Assist Devices") OR "LVAD" OR "BiVAD" OR "ventric* assist device" OR "Left ventric* assist device" OR "Biventricular assist device" OR "Biventricle assist device" OR "Heart assist device")) AND ((((MH "Infection") OR "infection") OR ((MH "Bacteremia") OR "bactremia" OR "blood stream infection" OR "BSI") OR ((MH "Surgical Wound Infection") OR "surgical wound infection" OR "surgical site infection" OR "SSI")))) AND (((MH "Obesity") OR "obesity")) was used and applied same filter. Patients with grade one obesity or more were observed to experience some weight loss while on the left ventricular assist devices. It was concluded that, while on left ventricular assist devices, patients living with obesity are entitled to equal liberty of death or delisting. On the same note, it was perceived that grade two or more obese patients were entitled to some greater tricky situation jeopardies (Raymond et al.
The finding called for the United Network of Organ Sharing to advance the listing of the grade two obesity patients while on the left ventricular assist devices. While on a left ventricular assist device, corpulent patients have the same liberty from death or delisting. Group study ensures high-quality outcomes and information leading to accurate conclusions (Gordon et al. According to the research conducted, cases of infections directly associated with the Ventricular Assist Devices appear at the rate of 14% to 59% of the occurrences. The bloodstream infections and the sternal would disease are examples of the infections associated with ventricular assist devices (Raymond et al. The articles can be perceived to be of great help to the general public at large. Information provided by the articles can only be described as of high quality.
It is clear from the group studies conducted that obesity influences bloodstream and surgical site infections. Strengths and weakness Group studies or multiple center studies of cardiac health has played a significant role in realizing the effects of obesity on LVAD patients. It is as a result of the group studies in the United States that cases and effects of obesity on cardiac health have been made known (Clerkin et al. Despite the weakness of the group studies, their strengths and advantages prevail. Group study ensures high-quality outcomes and information leading to accurate conclusions (Gordon et al. Topkara, V. K. The impact of obesity on patients bridged to transplantation with continuous-flow left ventricular assist devices. JACC: Heart Failure, 4(10), 761-768. Díaz, E.
J. Weinberg, A. D. Pagani, F. D. C. Kim, Y. J. Kim, T. H. Wellington, L. Stevenson, K. B. Mangino, J. E. Kfoury, A. G. Bishop, C. J. Davis, E.
From $10 to earn access
Only on Studyloop